$376 Million is the total value of Parkman Healthcare Partners LLC's 81 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 38.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $28,004,219 | +62.6% | 100,702 | +22.4% | 7.46% | +52.3% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $17,024,260 | +26.4% | 367,933 | +5.8% | 4.53% | +18.4% |
UNH | Buy | UNITEDHEALTH GROUP INC | $14,708,254 | +5.4% | 27,742 | +0.4% | 3.92% | -1.3% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $13,894,814 | +11.4% | 116,333 | -0.9% | 3.70% | +4.4% |
LLY | Sell | LILLY ELI & CO | $12,598,798 | +10.4% | 34,438 | -2.4% | 3.36% | +3.4% |
VRNA | Buy | VERONA PHARMA PLCsponsored ads | $10,829,526 | +227.8% | 414,448 | +28.2% | 2.88% | +207.1% |
SGEN | Buy | SEAGEN INC | $10,519,058 | +6.2% | 81,854 | +13.1% | 2.80% | -0.5% |
HAE | Buy | HAEMONETICS CORP MASS | $10,411,530 | +21.5% | 132,378 | +14.3% | 2.77% | +13.7% |
DHR | Sell | DANAHER CORPORATION | $10,190,270 | -25.6% | 38,393 | -27.6% | 2.71% | -30.3% |
XENE | Buy | XENON PHARMACEUTICALS INC | $9,285,410 | +15.5% | 235,491 | +5.8% | 2.47% | +8.2% |
HUM | New | HUMANA INC | $8,932,081 | – | 17,439 | +100.0% | 2.38% | – |
CTIC | Buy | CTI BIOPHARMA CORP | $8,465,938 | +20.2% | 1,408,642 | +16.4% | 2.25% | +12.6% |
PCVX | New | VAXCYTE INC | $7,578,402 | – | 158,048 | +100.0% | 2.02% | – |
DXCM | Buy | DEXCOM INC | $7,103,545 | +118.6% | 62,730 | +55.4% | 1.89% | +104.8% |
CNCE | Buy | CONCERT PHARMACEUTICALS INC | $7,028,347 | -7.8% | 1,203,484 | +5.8% | 1.87% | -13.6% |
STRO | Buy | SUTRO BIOPHARMA INC | $6,997,078 | +83.4% | 865,975 | +26.0% | 1.86% | +71.7% |
ANTM | Sell | ELEVANCE HEALTH INC | $6,307,479 | -19.2% | 12,296 | -28.5% | 1.68% | -24.4% |
THC | Sell | TENET HEALTHCARE CORP | $6,172,179 | -24.7% | 126,505 | -20.4% | 1.64% | -29.5% |
KROS | Buy | KEROS THERAPEUTICS INC | $6,088,456 | +62.0% | 126,790 | +26.9% | 1.62% | +51.6% |
CDMO | Buy | AVID BIOSERVICES INC | $5,897,250 | -23.8% | 428,268 | +5.8% | 1.57% | -28.6% |
DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $5,653,239 | +1.2% | 344,920 | +14.3% | 1.50% | -5.2% |
MNKD | Buy | MANNKIND CORP | $5,433,944 | +90.1% | 1,031,109 | +11.5% | 1.45% | +78.0% |
IONS | Sell | IONIS PHARMACEUTICALS INC | $5,329,914 | -50.2% | 141,115 | -41.7% | 1.42% | -53.4% |
PODD | Buy | INSULET CORP | $5,311,384 | +35.8% | 18,042 | +5.8% | 1.41% | +27.2% |
ESPR | Buy | ESPERION THERAPEUTICS INC NE | $5,125,944 | +158.1% | 822,784 | +177.6% | 1.36% | +141.6% |
ANIP | Buy | ANI PHARMACEUTICALS INC | $5,104,141 | +34.6% | 126,874 | +7.6% | 1.36% | +26.1% |
SILK | New | SILK RD MED INC | $4,931,169 | – | 93,305 | +100.0% | 1.31% | – |
DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $4,830,874 | +13.7% | 224,483 | +5.8% | 1.29% | +6.5% |
PFMT | Buy | PERFORMANT FINL CORP | $4,764,027 | +151.7% | 1,319,675 | +29.0% | 1.27% | +135.9% |
Buy | PROCEPT BIOROBOTICS CORP | $4,665,690 | +11.2% | 112,318 | +11.0% | 1.24% | +4.1% | |
LNTH | Buy | LANTHEUS HLDGS INC | $4,633,436 | +66.0% | 90,923 | +129.1% | 1.23% | +55.6% |
RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $4,596,941 | -0.2% | 157,862 | -16.0% | 1.22% | -6.5% |
LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $4,589,245 | -7.2% | 91,932 | -24.2% | 1.22% | -13.1% |
SRPT | New | SAREPTA THERAPEUTICS INC | $4,575,988 | – | 35,314 | +100.0% | 1.22% | – |
SDGR | Buy | SCHRODINGER INC | $4,260,404 | +37.9% | 227,951 | +84.3% | 1.13% | +29.2% |
ETNB | Buy | 89BIO INC | $4,237,562 | +225.2% | 332,880 | +47.9% | 1.13% | +204.9% |
BIIB | New | BIOGEN INC | $4,213,892 | – | 15,217 | +100.0% | 1.12% | – |
EW | Sell | EDWARDS LIFESCIENCES CORP | $4,072,139 | -39.8% | 54,579 | -33.4% | 1.08% | -43.7% |
ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,892,754 | +5.9% | 247,159 | +5.8% | 1.04% | -0.8% |
Sell | ARCELLX INC | $3,751,461 | +42.9% | 121,093 | -13.4% | 1.00% | +33.9% | |
KRTX | Buy | KARUNA THERAPEUTICS INC | $3,713,850 | +37.6% | 18,900 | +57.5% | 0.99% | +28.9% |
TMDX | Buy | TRANSMEDICS GROUP INC | $3,416,264 | +93.2% | 55,351 | +30.7% | 0.91% | +80.9% |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $3,385,297 | +11.5% | 94,906 | +5.8% | 0.90% | +4.4% |
COO | Sell | COOPER COS INC | $3,306,700 | +18.0% | 10,000 | -5.9% | 0.88% | +10.5% |
IQV | Sell | IQVIA HLDGS INC | $3,149,979 | -50.6% | 15,374 | -56.3% | 0.84% | -53.7% |
WAT | Sell | WATERS CORP | $3,016,074 | -59.5% | 8,804 | -68.1% | 0.80% | -62.1% |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $2,865,779 | +76.9% | 191,307 | +51.6% | 0.76% | +65.5% |
IMVT | New | IMMUNOVANT INC | $2,804,607 | – | 158,006 | +100.0% | 0.75% | – |
ATEC | Sell | ALPHATEC HLDGS INC | $2,801,807 | -41.2% | 226,867 | -58.4% | 0.75% | -44.9% |
VCYT | Buy | VERACYTE INC | $2,793,638 | +176.3% | 117,726 | +93.4% | 0.74% | +159.2% |
BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $2,703,427 | +42.8% | 91,332 | +12.3% | 0.72% | +33.8% |
KRMD | Buy | KORU MEDICAL SYSTEMS INC | $2,581,310 | +69.4% | 723,056 | +5.8% | 0.69% | +58.7% |
XFOR | Buy | X4 PHARMACEUTICALS INC | $2,358,928 | +45.2% | 2,375,557 | +150.1% | 0.63% | +35.9% |
Buy | RXSIGHT INC | $2,235,254 | +11.7% | 176,421 | +5.8% | 0.60% | +4.6% | |
NTRA | Sell | NATERA INC | $2,148,774 | -53.4% | 53,492 | -49.2% | 0.57% | -56.4% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $2,130,725 | +51.9% | 7,341 | -66.0% | 0.57% | +42.1% |
SLN | Buy | SILENCE THERAPEUTICS PLCads | $2,056,341 | +60.8% | 134,842 | +5.8% | 0.55% | +50.5% |
AXGN | Sell | AXOGEN INC | $1,896,749 | -20.4% | 190,055 | -5.0% | 0.50% | -25.5% |
RCUS | Sell | ARCUS BIOSCIENCES INC | $1,808,673 | -49.9% | 87,460 | -36.6% | 0.48% | -53.0% |
LQDA | Buy | LIQUIDIA CORPORATION | $1,714,753 | +23.9% | 269,192 | +5.8% | 0.46% | +16.3% |
COGT | Sell | COGENT BIOSCIENCES INC | $1,636,688 | -53.7% | 141,582 | -40.2% | 0.44% | -56.6% |
ISEE | Buy | IVERIC BIO INC | $1,583,441 | +76.5% | 73,958 | +47.9% | 0.42% | +65.5% |
FULC | Sell | FULCRUM THERAPEUTICS INC | $1,505,984 | -20.9% | 206,866 | -12.1% | 0.40% | -25.9% |
AGIO | New | AGIOS PHARMACEUTICALS INC | $1,404,000 | – | 50,000 | +100.0% | 0.37% | – |
CGEM | New | CULLINAN ONCOLOGY INC | $1,386,038 | – | 131,378 | +100.0% | 0.37% | – |
AKYA | Sell | AKOYA BIOSCIENCES INC | $1,351,810 | -28.9% | 141,255 | -12.6% | 0.36% | -33.3% |
TELA | Buy | TELA BIO INC | $1,341,682 | +42.7% | 116,668 | +5.8% | 0.36% | +33.7% |
LNDC | Buy | LIFECORE BIOMEDICAL INC | $1,319,185 | -26.6% | 203,578 | +0.7% | 0.35% | -31.3% |
New | SIGHT SCIENCES INC | $1,283,295 | – | 105,102 | +100.0% | 0.34% | – | |
OPNT | Sell | OPIANT PHARMACEUTICALS INC | $1,215,644 | +47.7% | 59,943 | -21.7% | 0.32% | +38.5% |
CYTK | New | CYTOKINETICS INC | $1,145,500 | – | 25,000 | +100.0% | 0.30% | – |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $1,028,703 | +15.5% | 52,754 | +24.4% | 0.27% | +8.3% |
GH | New | GUARDANT HEALTH INC | $952,000 | – | 35,000 | +100.0% | 0.25% | – |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $804,496 | +10.4% | 421,202 | +38.7% | 0.21% | +3.4% |
TKNO | Buy | ALPHA TEKNOVA INC | $724,503 | +78.4% | 128,458 | +5.8% | 0.19% | +67.8% |
IMUX | Sell | IMMUNIC INC | $643,678 | -69.0% | 459,770 | -30.1% | 0.17% | -71.1% |
TVTX | Sell | TRAVERE THERAPEUTICS INC | $480,220 | -26.7% | 22,835 | -14.0% | 0.13% | -31.2% |
EWTX | Buy | EDGEWISE THERAPEUTICS INC | $472,890 | -3.9% | 52,896 | +5.8% | 0.13% | -10.0% |
PSTV | Sell | PLUS THERAPEUTICS INC | $184,959 | -68.7% | 583,467 | -56.0% | 0.05% | -70.8% |
New | UNITY BIOTECHNOLOGY INC | $117,132 | – | 42,749 | +100.0% | 0.03% | – | |
AFIB | New | ACUTUS MED INC | $59,831 | – | 52,027 | +100.0% | 0.02% | – |
UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -404,092 | -100.0% | -0.04% | – |
SIEN | Exit | SIENTRA INC | $0 | – | -373,586 | -100.0% | -0.07% | – |
BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -288,852 | -100.0% | -0.08% | – |
STIM | Exit | NEURONETICS INC | $0 | – | -85,866 | -100.0% | -0.08% | – |
CDXS | Exit | CODEXIS INC | $0 | – | -105,319 | -100.0% | -0.18% | – |
VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -35,358 | -100.0% | -0.21% | – |
HBIO | Exit | HARVARD BIOSCIENCE INC | $0 | – | -305,353 | -100.0% | -0.22% | – |
ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -15,173 | -100.0% | -0.24% | – |
Exit | PEPGEN INC | $0 | – | -100,000 | -100.0% | -0.26% | – | |
XAIR | Exit | BEYOND AIR INC | $0 | – | -126,442 | -100.0% | -0.27% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -10,873 | -100.0% | -0.62% | – |
ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -15,000 | -100.0% | -0.80% | – |
Exit | IMAGO BIOSCIENCES INC | $0 | – | -189,193 | -100.0% | -0.81% | – | |
NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -242,600 | -100.0% | -0.88% | – |
IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -25,458 | -100.0% | -0.91% | – |
CTLT | Exit | CATALENT INC | $0 | – | -45,304 | -100.0% | -0.93% | – |
APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -657,690 | -100.0% | -1.03% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -42,961 | -100.0% | -1.04% | – |
TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -7,500 | -100.0% | -1.08% | – |
Exit | R1 RCM INC | $0 | – | -278,486 | -100.0% | -1.47% | – | |
CVS | Exit | CVS HEALTH CORP | $0 | – | -117,634 | -100.0% | -3.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 16 | Q3 2023 | 6.3% |
ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
NATERA INC | 16 | Q3 2023 | 3.4% |
AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
MANNKIND CORP | 15 | Q3 2023 | 1.6% |
IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.